Phase III Vaccine Trial in Africa Gives Poor Results about New Malaria Drug

mosquito-malaria

A phase III clinical trial in Africa of the RTS,S/AS01 malaria vaccine has reported disappointing results. The vaccine failed to show substantial protection for infants who received their first shot between 6 and 12 weeks of age.

Read more @ SciTechDaily

0 Responses to “Phase III Vaccine Trial in Africa Gives Poor Results about New Malaria Drug”



  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




subscribe to feed

About

ranjitwithkinginbehand.jpgI'm Range, your host. On the menu, photos, art, stories, entertainment and reviews. Links, maths, education and social issues. I'm in Quebec (Canada) or Taiwan (R.O.C.). Follow me on Twitter.

click to subscribe to The Memoirs & receive updates by email.

Join 1,691 other followers

@djrange: my tweets

channels

archives

del.icio.us

translate the memoirs

copyright notice & disclaimer

Please view the full disclaimer and copyright notice here
free web tracker

© 2006-2012 Range all rights reserved


%d bloggers like this: